Novel alpha1-adrenergic receptor signaling pathways: secreted factors and interactions with the extracellular matrix

Mol Pharmacol. 2006 Jul;70(1):129-42. doi: 10.1124/mol.105.020735. Epub 2006 Apr 14.

Abstract

alpha1-Adrenergic receptor (alpha1-ARs) subtypes (alpha1A, alpha1B, and alpha1D) regulate multiple signal pathways, such as phospholipase C, protein kinase C (PKC), and mitogen-activated protein kinases. We employed oligonucleotide microarray technology to explore the effects of both short- (1 h) and long-term (18 h) activation of the alpha1A-AR to enable RNA changes to occur downstream of earlier well characterized signaling pathways, promoting novel couplings. Polymerase chain reaction (PCR) studies confirmed that PKC was a critical regulator of alpha1A-AR-mediated gene expression, and secreted interleukin (IL)-6 also contributed to gene expression alterations. We next focused on two novel signaling pathways that might be mediated through alpha1A-AR stimulation because of the clustering of gene expression changes for cell adhesion/motility (syndecan-4 and tenascin-C) and hyaluronan (HA) signaling. We confirmed that alpha1-ARs induced adhesion in three cell types to vitronectin, an interaction that was also integrin-, FGF7-, and PKC-dependent. alpha1-AR activation also inhibited cell migration, which was integrin- and PKC-independent but still required secretion of FGF7. alpha1-AR activation also increased the expression and deposition of HA, a glycosaminoglycan, which displayed two distinct structures: pericellular coats and long cable structures, as well as increasing expression of the HA receptor, CD44. Long cable structures of HA can bind leukocytes, which this suggests that alpha1-ARs may be involved in proinflammatory responses. Our results indicate alpha1-ARs induce the secretion of factors that interact with the extracellular matrix to regulate cell adhesion, motility and proinflammatory responses through novel signaling pathways.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Adrenergic alpha-1 Receptor Antagonists
  • Adrenergic alpha-Antagonists / pharmacology
  • Alkaloids
  • Animals
  • Benzophenanthridines
  • Blotting, Western
  • Cell Adhesion / drug effects
  • Cell Adhesion / genetics
  • Cell Line, Transformed
  • Cell Movement / drug effects
  • Cell Movement / genetics
  • Extracellular Matrix / metabolism
  • Extracellular Matrix Proteins / genetics
  • Extracellular Matrix Proteins / metabolism
  • Fibroblast Growth Factor 7 / genetics
  • Fibroblast Growth Factor 7 / metabolism
  • Gene Expression Profiling
  • Interleukin-6 / genetics
  • Interleukin-6 / metabolism
  • Models, Biological
  • Oligonucleotide Array Sequence Analysis / methods
  • Phenanthridines / pharmacology
  • Prazosin / pharmacology
  • Protein Binding
  • Protein Kinase C / antagonists & inhibitors
  • Protein Kinase C / metabolism
  • Rats
  • Receptors, Adrenergic, alpha-1 / genetics
  • Receptors, Adrenergic, alpha-1 / physiology*
  • Reverse Transcriptase Polymerase Chain Reaction
  • Signal Transduction / drug effects
  • Signal Transduction / physiology*
  • Time Factors
  • Vitronectin / genetics
  • Vitronectin / metabolism

Substances

  • Adrenergic alpha-1 Receptor Antagonists
  • Adrenergic alpha-Antagonists
  • Alkaloids
  • Benzophenanthridines
  • Extracellular Matrix Proteins
  • Fgf7 protein, rat
  • Interleukin-6
  • Phenanthridines
  • Receptors, Adrenergic, alpha-1
  • Vitronectin
  • Fibroblast Growth Factor 7
  • chelerythrine
  • Protein Kinase C
  • Prazosin